The Challenges and Benefits of Generative AI in Health Care
Jan 17, 2024
auto_awesome
Renowned cardiologist and scientist, Eric Topol, discusses the challenges and benefits of AI in healthcare, the pros and cons of different models, and the medical technology that has been transformative. They explore the potential of generative AI in personalized medicine and note-taking, and the ethical implications. They also cover breakthrough drugs for inflammation and Alzheimer's prevention, GLP 1 drugs for diabetes and obesity, and the risks and uncertainties of generative AI in healthcare.
Generative AI has a lot to offer in health care, assisting with tasks like note-taking and patient follow-up.
The integration of GPT-4 with other systems and reliable databases can lead to more effective and dependable healthcare solutions.
Deep dives
The Impact of AI on Healthcare
Dr. Eric Toppel discusses the role of AI in healthcare and its potential to restore care in the field. While the medical community tends to be resistant to change, AI has the potential to address unmet and desperate needs in medicine. AI models like GPT-4 can assist in areas such as note-taking, pre-authorization, and patient follow-up. Despite concerns about errors and hallucinations, there is optimism that the technology will improve and that humans will always be in the loop for critical decision-making.
Transforming Medicine with Large Language Models
The conversation explores the potential of large language models like GPT-4 in revolutionizing healthcare. These models, although persuasive and seductive, are still part of a larger architecture that needs to be developed to ensure reliability and robustness. The discussion emphasizes the need for transparency and explainability in these models. It is predicted that future products will integrate GPT-4 with other systems, retrieval augmented generation, and link responses to reliable databases, leading to more effective and dependable healthcare solutions.
The Breakthrough of GLP-1 Agonists
The podcast highlights the remarkable impact of GLP-1 agonists, such as Ozempic, in the medical field. These drugs have shown significant potential in addressing cravings, reducing inflammation, and treating various medical conditions beyond diabetes and obesity. The conversation raises questions about the long-term effects and scalability of these drugs, as they rapidly diffuse into the population. However, the potential benefits in terms of improved patient experiences, coaching for empathy, and addressing medical conditions are considerable.
Artificial Intelligence is on every business leader’s agenda. How do we make sense of the fast-moving new developments in AI over the past year? Azeem Azhar returns to bring clarity to leaders who face a complicated information landscape.
Generative AI has a lot to offer health care professionals and medical scientists. This week, Azeem speaks with renowned cardiologist, scientist, and author Eric Topol about the change he’s observed among his colleagues in the last two years, as generative AI developments have accelerated in medicine.
They discuss:
The challenges and benefits of AI in health care.
The pros and cons of different open-source and closed-source models for health care use.
The medical technology that has been even more transformative than AI in the past year.